The infection fatality rate of COVID-19 inferred from seroprevalence data
John P.A. Ioannidis
doi: https://doi.org/10.1101/2020.05.13.20101253
John P.A. Ioannidis
Departments of Medicine, of Epidemiology and Population Health, of Biomedical Data Science, and of Statistics and Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA

Article usage
Posted May 19, 2020.
The infection fatality rate of COVID-19 inferred from seroprevalence data
John P.A. Ioannidis
medRxiv 2020.05.13.20101253; doi: https://doi.org/10.1101/2020.05.13.20101253
Subject Area
Subject Areas
- Addiction Medicine (271)
- Allergy and Immunology (553)
- Anesthesia (135)
- Cardiovascular Medicine (1761)
- Dermatology (173)
- Emergency Medicine (312)
- Epidemiology (10803)
- Gastroenterology (592)
- Genetic and Genomic Medicine (2953)
- Geriatric Medicine (287)
- Health Economics (534)
- Health Informatics (1930)
- Health Policy (836)
- Hematology (293)
- HIV/AIDS (631)
- Medical Education (299)
- Medical Ethics (86)
- Nephrology (324)
- Neurology (2801)
- Nursing (151)
- Nutrition (433)
- Oncology (1469)
- Ophthalmology (444)
- Orthopedics (172)
- Otolaryngology (257)
- Pain Medicine (190)
- Palliative Medicine (56)
- Pathology (381)
- Pediatrics (867)
- Primary Care Research (337)
- Public and Global Health (5374)
- Radiology and Imaging (1013)
- Respiratory Medicine (726)
- Rheumatology (330)
- Sports Medicine (279)
- Surgery (327)
- Toxicology (47)
- Transplantation (150)
- Urology (126)